• The myeloid neoplasms contain acute and chronic leukemias, myelodysplastic syndromes (MDSs) and myeloproliferative neoplasms (MPNs). (wikipedia.org)
  • We retrospectively analyzed the bone marrow biopsy of two MPNs cohorts of patients with polycythemia (PV) (n=64) and non-PV patients [including essential thrombocythemia (ET), and early/prefibrotic primary myelofibrosis (PMF)] (n=222). (unicatt.it)
  • Imago is a clinical stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms (MPNs) and other bone marrow diseases. (merck.com)
  • Purpose: The objectives of this study were 1) to assess PV reporting to the PCR in 2006-2009, 2) to determine whether a cancer cluster persisted, and 3) to determine whether other myeloproliferative neoplasms (MPNs), including essential thrombocytopenia (ET), were subject to similar reporting problems. (cdc.gov)
  • ATSDR used findings to estimate PV incidence neoplasms (MPNs). (cdc.gov)
  • The results of this evalu- ized by bone marrow proliferation and peripheral blood ation indicated that inaccurate reporting of PV to the PCR erythrocytosis, thrombocytosis, or granulocytoses.1 In addi- led to PV risk estimates that were inflated over true values tion to PV, the MPNs include chronic myeloid leukemia by 13% to 62%2. (cdc.gov)
  • Is one of a related group of blood cancers known as "myeloproliferative neoplasms" (MPNs). (schoolandyouth.org)
  • CD123 is a cell surface target expressed on a wide range of malignancies including blastic plasmacytoid dendritic cell neoplasm (BPDCN), certain myeloproliferative neoplasms (MPNs) including chronic myelomonocytic leukemia (CMML) and myelofibrosis (MF), acute myeloid leukemia (AML) (and potentially enriched in certain AML subsets), myelodysplastic syndrome (MDS), and chronic myeloid leukemia (CML). (menarini.es)
  • Myeloproliferative neoplasms (MPNs) are blood conditions caused by genetic mutations in blood stem cells in the bone marrow. (mympnteam.com)
  • The World Health Organization (WHO) provides diagnostic criteria for BCR-ABL negative MPNs, including polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF), chronic eosinophilic leukemia (CEL), chronic neutrophilic leukemia (CNL), and myeloproliferative neoplasms, unclassifiable (MPN-U) (1). (iranpath.org)
  • Myeloproliferative neoplasms (MPNs) are bone marrow diseases characterized by excess clonal hematopoiesis resulting in elevated peripheral blood counts. (researchgate.net)
  • Philadelphia-negative myeloproliferative neoplasms (MPNs) include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). (researchgate.net)
  • Previously known as myeloproliferative disorders (MPDs), the MPNs include essential thrombocytosis (ET), primary idiopathic myelofibrosis (IM), and chronic myelogenous leukemia (CML). (cdc.gov)
  • Myeloproliferative neoplasms, or MPNs - also called myeloproliferative disorders, or MPDs - are a collection of blood disorders that are believed to be caused by mutations in bone marrow stem cells. (ucsfhealth.org)
  • MPNs can sometimes transform to leukemia or to myelofibrosis, an MPN that is characterized by excessive scar-type tissue in the bone marrow. (ucsfhealth.org)
  • The myeloproliferative neoplasms (MPNs) are a heterogeneous group of chronic hematological malignancies that are generally divided into the Philadelphia chromosome-positive (Ph-positive) MPNs, which refers to chronic myelogenous leukemia (CML) and the Philadelphia chromosome-negative (Ph-negative) MPNs. (cancernetwork.com)
  • Myeloproliferative neoplasms (MPNs) are a group of chronic, rare diseases of the blood-forming cells in the bone marrow. (aop-health.com)
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) was previously known as natural killer (NK) cell leukemia/lymphoma. (lls.org)
  • As understanding of the biology and origin of this malignancy has improved, the World Health Organization (WHO) established the term blastic plasmacytoid dendritic cell neoplasm (BPDCN) in 2008. (lls.org)
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is very often misdiagnosed and under-reported. (lls.org)
  • FLORENCE, November 13th, 2020 - The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion on the approval of ELZONRIS (tagraxofusp) as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), an aggressive hematologic malignancy with dismal outcomes. (menarini.es)
  • Chronic myelomonocytic leukemia (CMML) is a type of leukemia, which are cancers of the blood-forming cells of the bone marrow. (wikipedia.org)
  • The Center for Leukemia at the Mass General Cancer Center provides treatments and clinical trials for all types of acute and chronic leukemia and related blood disorders. (massgeneral.org)
  • Sometimes chronic myeloproliferative disorders become Acute Leukemia, a condition where too many abnormal white blood cells are made and do not work properly. (massgeneral.org)
  • Certain myeloproliferative neoplasms may become acute myeloid leukemia (AML). (merck.com)
  • Malignant myelofibrosis (sometimes called acute myelofibrosis), is a rare variant of myelofibrosis characterized by pancytopenia, myeloblastosis, and marrow fibrosis that has a more rapidly progressive downhill course and is generally due to a type of acute leukemia called acute megakaryoblastic leukemia. (msdmanuals.com)
  • Common misdiagnoses for BPCDN include non-Hodgkin lymphoma (NHL), acute myeloid leukemia (AML), leukemia cutis (a nonspecific term used for cutaneous [skin] manifestation of any type of leukemia), melanoma (a type of skin cancer), and lupus erythematosus (chronic inflammatory disease that occurs when your body's immune system attacks your own tissues and organs). (lls.org)
  • Since granulocytes are involved in this type of leukemia, it is also referred to as CGL or chronic granulocytic leukemia. (mpninfo.org)
  • ELZONRIS is also being evaluated in additional clinical trials in other CD123+ indications, including chronic myelomonocytic leukemia (CMML), myelofibrosis (MF), acute myeloid leukemia (AML), and others are planned, including a CD123+ all-comers trial. (menarini.es)
  • It can also be used in cases of chronic myeloid leukemia (CML, also called chronic myelogenous leukemia) that have entered the aggressive blast phase - although kinase inhibitors have replaced chemotherapy in most of these cases. (mympnteam.com)
  • All the cancers that arise in the bone marrow are known as Leukemia. (mediflam.com)
  • ALL - Acute lymphoblastic leukemia, AML - Acute myeloid leukemia, APL - Acute promyelocytic leukemia, CLL - Chronic lymphocytic leukemia, CML - Chronic myeloid leukemia, and childhood leukemia are all types of Leukemia. (mediflam.com)
  • Treatment for Leukemia includes radiation therapy, Chemotherapy, Immunotherapy, Bone marrow transplant, etc. the treatment cost of Leukemia in India depends on the type and growth of leukemia in the body. (mediflam.com)
  • An increased M:E ratio (6:1) may be seen in infection, chronic myelogenous leukemia or erythroid hypoplasia. (assemblymade.com)
  • It has been postulated that monitoring measurable residual disease (MRD) could be used as a surrogate marker of progression-free survival (PFS) in chronic lymphocytic leukemia (CLL) patients after treatment with immunochemotherapy regimens. (haematologica.org)
  • A 30-year-old man with chronic neutrophilic leukemia (CNL) in association with monoclonal gammopathy is presented. (karger.com)
  • essential thrombocythemia refers to the abnormal overproduction of platelets, and chronic myeloid leukemia is generally associated with too many white blood cells. (ucsfhealth.org)
  • The molecular causes of the majority of MPN cases have been identified - mutations in the genes JAK2 and ABL are found in nearly all patients with polycythemia vera and chronic myeloid leukemia, respectively. (ucsfhealth.org)
  • In the case of chronic myeloid leukemia, the outlook of patients has been transformed dramatically as a result. (ucsfhealth.org)
  • Patients with chronic myelogenous leukemia and myelofibrosis often feel tired and report pain or fullness in their belly from an enlarged spleen. (ucsfhealth.org)
  • The treatment of choice for chronic myelogenous leukemia is a new anti-leukemia medication, called Gleevec. (ucsfhealth.org)
  • However, significant dysgranulopoiesis is not a feature of chronic myeloid leukemia (CML). (amjcaserep.com)
  • Its occurrence is linked to leukemic diseases of the myeloid cell line, most commonly in acute myeloid leukemia (AML) and less commonly in chronic myeloid leukemia (CML), myelodysplastic syndrome (MDS) or other myeloproliferative disorders [ 4 ]. (biomedcentral.com)
  • Objective evidence of a myeloid stem cell neoplasm in the form of a clonal cytogenetic abnormality is provided in only 30% to 40% of the non-chronic myeloid leukemia (CML) chronic MPDs (non-CML MPDs) and in a similar percentage of the MDSs. (nih.gov)
  • Decreased WBC count, leukopenia, is seen when supply is depleted by infection or treatment such as chemotherapy or radiation therapy, or when a hematopoietic stem cell abnormality does not allow normal growth/maturation within the bone marrow, such as myelodysplastic syndrome or leukemia. (medscape.com)
  • These malignancies are further characterized by the maturity and differentiation of the individual cell types and are divided into acute leukemias such as acute myeloid leukemia and acute lymphoblastic leukemia and chronic leukemias such as chronic myeloid leukemia and chronic lymphocytic leukemia. (medscape.com)
  • For leukemia, bias factors are to be derived from true dose determined for bone marrow. (cdc.gov)
  • These approaches were illustrated by applying them to data obtained in a study of the risk of any cancer excluding leukemia, and leukemia excluding chronic lymphocytic leukemia (CLL) in the Hanford workers. (cdc.gov)
  • Primary myelofibrosis: this condition causes scar tissue to grow inside the bone marrow. (massgeneral.org)
  • Primary myelofibrosis (PMF) is a chronic myeloproliferative neoplasm characterized by bone marrow fibrosis, splenomegaly, and anemia with nucleated and teardrop-shaped red blood cells. (msdmanuals.com)
  • Diagnosis requires bone marrow aspirate and biopsy and exclusion of other conditions that can cause myelofibrosis (secondary myelofibrosis). (msdmanuals.com)
  • Myelofibrosis is a reactive, reversible increase in bone marrow collagen often with extramedullary hematopoiesis (primarily in the spleen). (msdmanuals.com)
  • Primary myelofibrosis results from neoplastic transformation of a multipotent bone marrow stem cell. (msdmanuals.com)
  • These primary myelofibrosis progeny cells stimulate bone marrow fibroblasts (which are not part of the neoplastic transformation) to secrete excessive collagen. (msdmanuals.com)
  • In primary myelofibrosis, nucleated red blood cells (normoblasts) and myelocytes are released into the circulation (leukoerythroblastosis) when there is extramedullary hematopoiesis (ie, non-marrow organs have taken over blood cell production because of the fibrosed marrow). (msdmanuals.com)
  • Myelofibrosis is a disease of the bone marrow that causes an enlarged spleen. (psychokinesis.co.il)
  • Bone marrow fibrosis is a central pathological feature and World Health Organization major diagnostic criterion of myelofibrosis. (haematologica.org)
  • Although bone marrow fibrosis is seen in a variety of malignant and non-malignant disease states, the deposition of reticulin and collagen fibrosis in the bone marrow of patients with myelofibrosis is believed to be mediated by the myelofibrosis hematopoietic stem/progenitor cell, contributing to an impaired microenvironment favoring malignant over normal hematopoiesis. (haematologica.org)
  • However, modern myelofibrosis prognostication systems utilized in risk-adapted treatment approaches do not include bone marrow fibrosis as a prognostic variable. (haematologica.org)
  • The specific effect on bone marrow fibrosis of JAK2 inhibition, and other rationally based therapies currently being evaluated in myelofibrosis, has yet to be fully elucidated. (haematologica.org)
  • Hematopoietic stem cell transplantation remains the only curative therapeutic approach that reliably results in resolution of bone marrow fibrosis in patients with myelofibrosis. (haematologica.org)
  • 3 Myelofibrosis (MF) refers to the Philadelphia chromosome ( BCR-ABL1 )-negative myeloproliferative neoplasm (MPN) originating at the level of the multipotent hematopoietic stem cell. (haematologica.org)
  • Primary myelofibrosis, also known as idiopathic myelofibrosis and agnogenic myeloid metaplasia, is a malignant disease, one of the chronic myeloproliferative neoplasms, along with polycythemia vera and essential thrombocythemia, amongst others (see table 1). (fcarreras.org)
  • Primary myelofibrosis is characterised by the presence of a fibrous tissue in the bone marrow, and by the migration of bone marrow stem cells to the blood, where they colonise organs from a distance (mainly the spleen and the liver). (fcarreras.org)
  • A proportion of patients with polycythemia vera and essential thrombocythemia will, over the course of time, develop symptoms of bone marrow fibrosis indistinguishable from that in primary myelofibrosis. (fcarreras.org)
  • Myelofibrosis (MF) is a hematopoietic stem cell malignancy classified as a myeloproliferative neoplasm (MPN). (cancernetwork.com)
  • Myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes-disorders that include features of both myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN)-are entities whose diagnosis and management have proved challenging. (medscape.com)
  • For diagnosis it is essential to perform a bone marrow analysis and biopsy. (fcarreras.org)
  • A bone marrow biopsy is performed to confirm a diagnosis of MPN. (ucsfhealth.org)
  • There was evident dysgranulopoiesis that raised a provisional diagnosis of myelodysplastic/myeloproliferative neoplasm. (amjcaserep.com)
  • Effects of hematopoietic stem cell adhesion on marrow stromal cell cytokine p. (rochester.edu)
  • The 2008 revision of the classification moved cases of CMML with PDGFR gene translocations to a new group, myeloid/lymphoid neoplasms with eosinophilia with abnormalities of PDGFRA, PDGFRB or FGFR1. (wikipedia.org)
  • In the recent fifth edition of the World Health Organization classification, similar to the recent update to the International Consensus Classification, the category was renamed to "myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions" and both classifications added novel subtypes with new JAK2 rearrangements (e.g. (nature.com)
  • They might involve medicines, blood transfusions or a bone marrow transplant . (medlineplus.gov)
  • Bone Marrow Transplant, the only cure for an MPN, but is expensive and comes with high risk. (mpninfo.org)
  • ABMT autologous bone marrow transplant your own marrow. (mpninfo.org)
  • BMT allogeneic bone marrow transplant someone else's marrow MUD-bone marrow transplant marrow from matched unrelated donor SBMT-syngeneic bone marrow transplant identical twin's marrow PBPC peripheral blood progenitor cell transplant PBSCT peripheral blood stem cell transplant PBSCR peripheral blood stem cell rescue PSCT or PSCR same as above without the word "blood. (mpninfo.org)
  • It is due to this very reason that patients undergoing a bone marrow transplant are recommended to enhance their protein intake. (assemblymade.com)
  • It is important to talk to other patients to take their fear", said Peter Lercher from the Associazione Italiana Pazienti con Malattie Mieloproliferative (AIPAMM) in Italy, who had a bone marrow transplant last year. (aop-health.com)
  • previous names included blastic NK cell lymphoma and agranular CD4+/CD56+ hematodermic neoplasm. (menarini.es)
  • Bone marrow core biopsies may show a predominance of myelocytic and monocytic cells, abnormal localisation of immature precursors and dysplastic megakaryocytes. (wikipedia.org)
  • Similarly, only a trephine biopsy shows the architecture of the bone marrow and permits the detection of an abnormal distribution of cells, bone marrow granulomas, and focal lymphoid infiltrates. (bmj.com)
  • Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. (lookformedical.com)
  • Neuropathic pain is one of the most debilitating forms of chronic pain, resulting from an injury or disease of the somatosensory nervous system, which induces abnormal painful sensations including allodynia and hyperalgesia. (researchgate.net)
  • JAK2 V617F and exon 12 genetic variations in Korean patients with BCR/ABL1-negative myeloproliferative neoplasms]. (cdc.gov)
  • TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings. (cdc.gov)
  • T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms. (cdc.gov)
  • Seventy-one patients with BCR-ABL negative myeloproliferative neoplasms were evaluated for JAK2 V617F, CALR type 1, type 2, and MPL by allele-specific PCR and conventional PCR from 2018 to 2019. (iranpath.org)
  • Seventy-one patients with BCR-ABL negative myeloproliferative neoplasms whose information was registered in the molecular pathology department of Shiraz Medical School, the southwest of Iran, were included in this study from 2018 to 2019. (iranpath.org)
  • The diagnostic approach proposed by the World Health Organization (WHO) uses clinical features, bone marrow (BM) morphology, karyotype and molecular genetic tests to classify MPN su. (researchgate.net)
  • We retrospectively evaluated 4-color flow cytometry data from more than 400 bone marrow aspirates obtained since 1998 from patients suspected of having a non-CML MPD or an MDS. (nih.gov)
  • In addition, we summarize data, presented in detail elsewhere, from a retrospective comparison of the sensitivity of flow cytometry with conventional cytogenetics for a large number of bone marrow aspirates on which both types of studies were performed. (nih.gov)
  • However, BPDCN usually progresses with bone marrow involvement and a decrease in red blood cell, white blood cell and platelet counts. (lls.org)
  • BPDCN typically presents in the bone marrow and/or skin and may also involve lymph nodes and viscera. (menarini.es)
  • Ideally, reporting of trephine biopsy sections should be done by an individual who is competent in both histopathology and haematology, and who is able to make an appropriate assessment of both the bone marrow aspirate and the trephine biopsy sections. (bmj.com)
  • Bone Marrow Biopsy removal of aspirate and solid tissue from marrow for analysis. (mpninfo.org)
  • We report here a patient from Bihar, presented to us with prolonged fever and pancytopenia, bone marrow aspirate showed microfilaria. (annexpublishers.co)
  • A primary malignant neoplasm of epithelial liver cells. (lookformedical.com)
  • Primary gastrointestinal (GI) neoplasms in children are rare entities. (medscape.com)
  • A very rare form is the primary extramedullary manifestation of AML with normal appearing bone marrow, which comprises less than 1% of all patients with AML [ 6 ]. (biomedcentral.com)
  • This study was conducted to evaluate the frequency of JAK2, CALR and MPL mutations in with BCR-ABL myeloproliferative neoplasms and their association with demographic data and hematologic parameters in a referral center, in the Middle East. (iranpath.org)
  • Patients' demographic data (like age and sex) and hematologic characteristics of myeloproliferative neoplasms (like hemoglobin level, leukocytosis, and platelet count) were extracted from the database registered in the department of molecular pathology. (iranpath.org)
  • Systemic mastocytosis (SM) with an associated hematologic neoplasm (SM-AHN) comprises 5% to 40% of cases of SM. (amjcaserep.com)
  • All types of hematologic neoplasms have been previously reported, although CML has been rarely encountered. (amjcaserep.com)
  • A bone marrow aspiration should be performed as part of the same procedure. (bmj.com)
  • If bone marrow aspiration is found to be impossible, imprints from the biopsy specimen should be obtained. (bmj.com)
  • Bone marrow aspiration showed myeloid hyperplasia without dysplastic features. (karger.com)
  • Clinical details and the results of relevant laboratory tests including the blood count and blood film features must be known before a bone marrow biopsy is performed. (bmj.com)
  • Although a detailed discussion of the overlap neoplasms is beyond the scope of this review, they share clinical, pathologic, and therapeutic features with MDS and can be treated similarly when they present with more features of MDS than MPN. (medscape.com)
  • Epithelioid angiosarcoma is a rare malignant neoplasm found in vascular endothelial cells. (bvsalud.org)
  • Epithelioid angiosarcoma (EA) is a rare variant of angiosarcoma, which is characterized by a high-grade malignant neoplasm, which consists of an atypical, multilayered, or solid endothelial proliferation and vasoformative architecture, presenting necrosis and an area of hemorrhage 1-5 . (bvsalud.org)
  • However, better understanding of the role of increased JAK-STAT signaling [either through activating mutations ( JAK2 , MPL515L/K ) within the signaling pathway, or mutations involving CALR ], the role of deregulated pro-inflammatory cytokine expression, and the impaired bone marrow microenvironment is transforming the treatment approach for MF. (haematologica.org)
  • Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype? (cdc.gov)
  • Collectively, mutations in U2AF1 induce expression of therapeutically targetable 'active' IRAK4 isoforms and provide a genetic link to activation of chronic innate immune signalling in MDS and AML. (cancer-genetics.org)
  • Due to the different frequency of JAK2, MPL, CALR mutations and the difference in the course of myeloproliferative neoplasms with different mutations and considering that a comprehensive study has not been established in the Iranian population about myeloproliferative neoplasms and these mutations so far, this study was conducted in a referral center in the southwest of Iran, the Middle East. (iranpath.org)
  • Autoantibodies and cold agglutinins may be present and 10% of CMML is DCT positive.Bone marrow aspirates will display hypercellularity with increased counts of granulocytic and monocytic cells. (wikipedia.org)
  • Unexplained pancytopenia and an unexplained leucoerythroblastic blood film are indications for a trephine biopsy because they are likely to indicate bone marrow infiltration or fibrosis. (bmj.com)
  • The DNA (genetic material) of a developing stem cell in the bone marrow is damaged. (schoolandyouth.org)
  • To identify normal patterns of antigen expression during myeloid maturation and to determine whether flow cytometric evaluation of myeloid maturation represents an additional objective way to assess the likelihood of a stem cell neoplasm. (nih.gov)
  • The mouse is the most sensitive species where the target organs are bone marrow, ovary and testis a NOAEL for repeat dose toxicity in the chronic studies has not been established due to neoplasia-related toxicity. (europa.eu)
  • Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status. (cdc.gov)
  • The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms. (cdc.gov)
  • The clinical course of individuals with MF is heterogeneous and characterized by constitutional symptoms, bone marrow myeloproliferation and fibrosis, progressive cytopenias, and symptomatic splenomegaly. (cancernetwork.com)
  • The clinical course of individuals with MF is characterized by constitutional symptoms (fevers, night sweats, and weight loss), bone marrow myeloproliferation and reticulin/collagen fibrosis, worsening cytopenias, thrombosis, and progressive symptomatic splenomegaly. (cancernetwork.com)
  • Bone marrow failure eventually occurs, with consequent anemia and thrombocytopenia. (msdmanuals.com)
  • In severe cases, MPN can lead to anemia and bone marrow failure. (psychokinesis.co.il)
  • In regenerative anemia, the red cells are reduced in number as the result of acute or chronic bleeding or destruction within the body. (catwatchnewsletter.com)
  • In nonregenerative anemia, the bone marrow fails to produce new cells rapidly enough to replace old cells that have been destroyed or are otherwise dysfunctional. (catwatchnewsletter.com)
  • Nonregenerative anemia also can be caused by certain feline medications, such as sulfa drugs, that depress bone marrow function. (catwatchnewsletter.com)
  • Consequently, this article focuses on the more common benign and malignant neoplasms of the GI tract in children, in addition to information gleaned from fairly sparse literature. (medscape.com)
  • Reproducible patterns of antigen expression were seen in normal myeloid maturation as well as in benign reactive settings such as marrow regeneration. (nih.gov)
  • JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil. (cdc.gov)
  • JAK2 46/1 haplotype is associated with JAK2 V617F--positive myeloproliferative neoplasms in Brazilian patients. (cdc.gov)
  • Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients. (cdc.gov)
  • Karyotypic and molecular analyses of bone marrow cells showed the absence of Philadelphia (Ph 1 ) chromosome and bcr gene rearrangement. (karger.com)